Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2017 1
2019 7
2020 11
2021 12
2022 3
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working Group.
Alfraih F, Absi A, Abuhaleeqa M, Alghamdi K, Alhuraiji A, Al-Khabori M, Al-Shaibani Z, Alzahrani M, Cherif H, Eldadah S, Hanbali A, Motabi IH, Salama H. Alfraih F, et al. Among authors: al shaibani z. Cancer Rep (Hoboken). 2024 Feb;7(2):e1931. doi: 10.1002/cnr2.1931. Epub 2023 Dec 11. Cancer Rep (Hoboken). 2024. PMID: 38083985 Free PMC article.
Prolactin, a potential biomarker for chronic GVHD activity.
Salas MQ, Ezzat S, Lam W, Law AD, Pasic I, Michelis FV, Kim DDH, Gerbitz A, Al-Shaibani Z, Viswabandya A, Kumar R, Mattsson J, Lipton JH. Salas MQ, et al. Among authors: al shaibani z. Eur J Haematol. 2021 Feb;106(2):158-164. doi: 10.1111/ejh.13531. Epub 2020 Oct 26. Eur J Haematol. 2021. PMID: 33047394
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care Center.
Linn SM, Nampoothiri RV, Chen C, Pasic I, Al-Shaibani Z, Lam W, Law AD, Michelis FV, Kim DDH, Gerbitz A, Lipton J, Kumar R, Mattsson J, Viswabandya A. Linn SM, et al. Among authors: al shaibani z. Hematol Oncol Stem Cell Ther. 2023 Apr 4;16(3):230-237. doi: 10.1016/j.hemonc.2021.09.008. Hematol Oncol Stem Cell Ther. 2023. PMID: 34856195 Free article.
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Nampoothiri RV, Law AD, Lam W, Chen C, Al-Shaibani Z, Loach D, Michelis FV, Kim DDH, Mattsson J, Kumar R, Lipton JH, Viswabandya A. Nampoothiri RV, et al. Among authors: al shaibani z. Hematol Oncol Stem Cell Ther. 2022 Mar 1;15(1):27-35. doi: 10.1016/j.hemonc.2021.03.003. Hematol Oncol Stem Cell Ther. 2022. PMID: 33775624 Free article.
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation.
Prem S, Remberger M, Alotaibi A, Lam W, Law AD, Kim DDH, Michelis FV, Al-Shaibani Z, Lipton JH, Mattsson J, Viswabandya A, Kumar R, Ellison C. Prem S, et al. Among authors: al shaibani z. Transpl Infect Dis. 2022 Aug;24(4):e13879. doi: 10.1111/tid.13879. Epub 2022 Jul 13. Transpl Infect Dis. 2022. PMID: 35706108
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients.
Al-Shaibani E, Bautista R, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law AD, Al-Shaibani Z, Gerbitz A, Pasic I, Mattsson J, Michelis FV. Al-Shaibani E, et al. Among authors: al shaibani z. Clin Lymphoma Myeloma Leuk. 2022 May;22(5):e327-e334. doi: 10.1016/j.clml.2021.11.004. Epub 2021 Nov 11. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34866020
30 results